🔗 Visit the ClinicalTrials.gov page for NCT01216839
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | New developments in mammalian target of rapamycin inhibitors for the treatment of sarcoma. | Cancer | 2011 | 0.85 |
| 2 | The angiogenic asset of soft tissue sarcomas: a new tool to discover new therapeutic targets. | Biosci Rep | 2014 | 0.83 |
| 3 | Pediatric sarcomas: translating molecular pathogenesis of disease to novel therapeutic possibilities. | Pediatr Res | 2012 | 0.82 |
| 4 | The importance of being dead: cell death mechanisms assessment in anti-sarcoma therapy. | Front Oncol | 2015 | 0.76 |
| 5 | Advances in paediatric cancer treatment. | Transl Pediatr | 2014 | 0.76 |